<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Accuracy and speed of molecular response reporting with Xpert BCR-ABL Ultra in vitro diagnostic test in CML patients</dc:title><dc:creator>Stangler Herodež,	Špela	(Avtor)
	</dc:creator><dc:creator>Kokalj-Vokač,	Nadja	(Avtor)
	</dc:creator><dc:creator>Roškar,	Zlatko	(Avtor)
	</dc:creator><dc:creator>Dreisinger,	Mojca	(Avtor)
	</dc:creator><dc:subject>chronic myeloid leukemia</dc:subject><dc:subject>BCR-ABL1 fusion gene</dc:subject><dc:subject>GeneXpert</dc:subject><dc:subject>minimal residual disease</dc:subject><dc:subject>molecular response</dc:subject><dc:date>2021</dc:date><dc:date>2023-01-22 21:36:54</dc:date><dc:type>Znanstveno delo</dc:type><dc:identifier>83671</dc:identifier><dc:identifier>UDK: 616.155.392</dc:identifier><dc:identifier>COBISS_ID: 68177923</dc:identifier><dc:identifier>DOI: 10.18690/actabiomed.215</dc:identifier><dc:identifier>ISSN pri članku: 1855-5640</dc:identifier><dc:language>sl</dc:language></metadata>
